Banner

July 25, 2008

Friday news briefs

Kendle Earnings Fall

With news about Quintiles, Bio-Trials, Chiltern, Synteract, MDS Pharma Services, SAS, ThotWave and Covance.

Wednesday News Briefs

CDISC Tech Survey

Bulletins about ClinPhone, IBM, drug safety in Arizona, Generex and Axiom.

Monday News Briefs

Akamai Web Accelerator

News from Omnicare Clinical, Wyeth, PPD, China.

Friday News Briefs

Big Wyeth Verdict

With news from Phase Forward, SkinGenix, INC Research, PharmaReady, Phoenix and bioRASI.

thumbnail
Friday news briefs

Kendle Earnings Fall

November 02, 2007

By info@clinpage.com

Top contract research organization Kendle reported a strong quarter but told Wall Street future profits would be lower than expected. Quarterly revenues jumped 33 percent to $100 million. The company lined up $175 million in new business. But net income…

thumbnail
Wednesday News Briefs

CDISC Tech Survey

October 17, 2007

By info@clinpage.com

ClinPhone, a leading clinical technology suite, has been granted a Best Technological Development in Clinical Trial Management Systems Award for its drug accountability solution at the inaugural GCPj Awards 2007. The Good Clinical Practice Journal Awards were developed to recognize…

thumbnail
Monday News Briefs

Akamai Web Accelerator

October 15, 2007

By info@clinpage.com

CDISC annointed Omnicare Clinical Research registered Registered Solutions Provider status. Said the company’s Mark Penniston, global VP of Biometrics: “Since our first CDISC conformant submission in early 2004, Omnicare Clinical Research has had a rich history of successful data conversions.…

thumbnail
Friday News Briefs

Big Wyeth Verdict

October 12, 2007

By info@clinpage.com

In Nevada, a jury ordered Wyeth to pay $135 million to three women who took Premarin and Prempro. The jury said Wyeth acted with malice or fraud. Wyeth has no reserve fund for its hormone replacement therapy (HRT) cases, possibly…

thumbnail
Strategies from Pfizer & Pacific Bridge

RAPS 2007: Going To India & China

October 04, 2007

By Mark Uehling

In a session about two of the most promising pharmaceutical markets (for both sales and clinical trials) the 2007 Regulatory Affairs Professionals Society conference had well-travelled speakers to a variety of countries. We happened to hear two presentations that were…